These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26397019)

  • 1. Fine-tuning of type I IFN-signaling in microglia--implications for homeostasis, CNS autoimmunity and interferonopathies.
    Goldmann T; Blank T; Prinz M
    Curr Opin Neurobiol; 2016 Feb; 36():38-42. PubMed ID: 26397019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon in neurological disease-the devil from within.
    Hofer MJ; Campbell IL
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):257-67. PubMed ID: 23548179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aicardi-Goutières syndrome and the type I interferonopathies.
    Crow YJ; Manel N
    Nat Rev Immunol; 2015 Jul; 15(7):429-40. PubMed ID: 26052098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon pathway in CNS homeostasis and neurological disorders.
    Blank T; Prinz M
    Glia; 2017 Sep; 65(9):1397-1406. PubMed ID: 28519900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome.
    Meuwissen ME; Schot R; Buta S; Oudesluijs G; Tinschert S; Speer SD; Li Z; van Unen L; Heijsman D; Goldmann T; Lequin MH; Kros JM; Stam W; Hermann M; Willemsen R; Brouwer RW; Van IJcken WF; Martin-Fernandez M; de Coo I; Dudink J; de Vries FA; Bertoli Avella A; Prinz M; Crow YJ; Verheijen FW; Pellegrini S; Bogunovic D; Mancini GM
    J Exp Med; 2016 Jun; 213(7):1163-74. PubMed ID: 27325888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.
    Carson MJ
    Glia; 2002 Nov; 40(2):218-231. PubMed ID: 12379909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
    Ding X; Yan Y; Li X; Li K; Ciric B; Yang J; Zhang Y; Wu S; Xu H; Chen W; Lovett-Racke AE; Zhang GX; Rostami A
    J Immunol; 2015 May; 194(9):4251-64. PubMed ID: 25795755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications.
    Magnus T; Chan A; Savill J; Toyka KV; Gold R
    J Neuroimmunol; 2002 Sep; 130(1-2):1-9. PubMed ID: 12225883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Type I Interferonopathies.
    Lee-Kirsch MA
    Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferonopathies in pediatric rheumatology.
    Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.
    Shemer A; Jung S
    Semin Immunopathol; 2015 Nov; 37(6):613-23. PubMed ID: 26240063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity.
    Thompson KK; Tsirka SE
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.
    Behrendt R; Roers A
    Clin Exp Immunol; 2014 Jan; 175(1):9-16. PubMed ID: 23713592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.
    Kuhlmann T; Wendling U; Nolte C; Zipp F; Maruschak B; Stadelmann C; Siebert H; Brück W
    J Neurosci Res; 2002 Jan; 67(2):185-90. PubMed ID: 11782962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease.
    West PK; Viengkhou B; Campbell IL; Hofer MJ
    Glia; 2019 Oct; 67(10):1821-1841. PubMed ID: 31033014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune T cell responses in the central nervous system.
    Goverman J
    Nat Rev Immunol; 2009 Jun; 9(6):393-407. PubMed ID: 19444307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking down the cellular responses to type I interferon neurotoxicity in the brain.
    Viengkhou B; Hofer MJ
    Front Immunol; 2023; 14():1110593. PubMed ID: 36817430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5.
    Onizawa H; Kato H; Kimura H; Kudo T; Soda N; Shimizu S; Funabiki M; Yagi Y; Nakamoto Y; Priller J; Nishikomori R; Heike T; Yan N; Tsujimura T; Mimori T; Fujita T
    Int Immunol; 2021 Mar; 33(4):225-240. PubMed ID: 33165593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type I interferonopathies].
    Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
    Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updating Neuroimmune Targets in Central Nervous System Dysfunction.
    Valente LA; Begg LR; Filiano AJ
    Trends Pharmacol Sci; 2019 Jul; 40(7):482-494. PubMed ID: 31130220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.